title: Response to publication of PRISM trial.
authors.forename: Ian R
authors.initials: IR
authors.lastname: Reid
authors.forename: Tim
authors.initials: T
authors.lastname: Cundy
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Bolland
authors.forename: Andrew
authors.initials: A
authors.lastname: Grey
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use; D018450:Disease Progression; D050723:Fractures, Bone / Q000150:complications / Q000188:drug therapy; D006801:Humans; D010001:Osteitis Deformans / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D011642:Publications
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000469:Alkaline Phosphatase